Tucatinib 150 Mg Tablet Tucaliv

About Tucatinib 150 Mg Tablet Tucaliv

Tucatinib 150 mg Tablets are a targeted anti-cancer medication used in the treatment of HER2-positive breast cancer, particularly in advanced or metastatic cases. Tucatinib is a selective tyrosine kinase inhibitor that specifically targets the HER2 receptor, helping to slow the growth and spread of cancer cells while minimizing effects on healthy cells.

Composition:

• Active Ingredient: Tucatinib

• Strength: 150 mg

• Dosage Form: Tablet

Therapeutic Use:

• Treatment of HER2-positive metastatic breast cancer

• Used in combination with other anti-cancer medicines as prescribed by an oncologist

Mechanism of Action:
Tucatinib selectively inhibits the HER2 tyrosine kinase, blocking cancer cell signaling pathways responsible for tumor growth and survival. Its high selectivity helps reduce off-target side effects compared to non-selective HER2 inhibitors.

Key Benefits:

• Targeted HER2 inhibition

• Effective in advanced and metastatic breast cancer

• Suitable for long-term oral therapy

• Clinically proven efficacy when used in combination regimens

Dosage & Administration:

• Dosage should be taken strictly as directed by a qualified oncologist

• Tablets should be swallowed whole with water

• Do not crush or chew

Storage Instructions:

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

Packaging:

• Strip / Bottle packing (as available)

Prescription Status:

• Prescription drug (Rx only)

Disclaimer:
This product is intended for use under the supervision of a registered medical practitioner. Dosage and treatment duration depend on the patients clinical condition.